Thomas Seidl, PhD
Pacific Diabetes Technologies, Portland, Oregon

Thomas assumed the role of CEO of Pacific Diabetes Technologies, Inc. in November 2020. He brings extensive experience in management, research, development, and clinical validation for diabetes technologies. Thomas joined PDT as Chief Science Officer in 2017 and led optimization of the chemistry and coating processes, the hollow sensor design and the development of the fabrication process. Prior to joining the Company, Thomas was Manager of Polymer Development at Bayer HealthCare, Diabetes Care. Thomas holds a BS in Chemistry (2000) and an MS in Cell and Molecular Biology (2002) from the University of Hawaii at Manoa. He earned his doctorate in Synthetic Organic Chemistry from Portland State University in 2017.